Cited by 254TGF-β signaling in diseasesCancer-related Molecular PathwaysCell death mechanisms and regulation

The DOI matches its Crossref record; 88 of the 88 references it cites were found in a registry or an index.

Placental Transforming Growth Factor-β Is a Downstream Mediator of the Growth Arrest and Apoptotic Response of Tumor Cells to DNA Damage and p53 Overexpression

Open access

Li, Pei-Xiang, Wong, Jeffrey, Ayed, Ayeda, Ngo, Duc, Brade, Anthony M., Arrowsmith, Cheryl, Austin, Richard C., Klamut, Henry J.·2000·Journal of Biological Chemistry

DOI 10.1074/jbc.m909580199

Open this paper in CoChat — free account Open PDF

Abstract

The p53 tumor suppressor gene and members of the transforming growth factor-beta (TGF-beta) superfamily play central roles in signaling cell cycle arrest and apoptosis (programmed cell death) in normal development and differentiation, as well as in carcinogenesis. Here we describe a distantly related member of the TGF-beta superfamily, designated placental TGF-beta (PTGF-beta), that is up-regulated in response to both p53-dependent and -independent apoptotic signaling events arising from DNA damage in human breast cancer cells. PTGF-beta is normally expressed in placenta and at lower levels in kidney, lung, pancreas, and muscle but could not be detected in any tumor cell line studied. The PTGF-beta promoter is activated by p53 and contains two p53 binding site motifs. Functional studies demonstrated that one of these p53 binding sites is essential for p53-mediated PTGF-beta promoter induction and specifically binds recombinant p53 in gel mobility shift assays. PTGF-beta overexpression from a recombinant adenoviral vector (AdPTGF-beta) led to an 80% reduction in MDA-MB-468 breast cancer cell viability and a 50-60% reduction in other human breast cancer cell lines studied, including MCF-7 cells, which are resistant to growth inhibition by recombinant wild-type p53. Like p53, PTGF-beta overexpression was seen to induce both G(1) cell cycle arrest and apoptosis in breast tumor cells. These results provide the first evidence for a direct functional link between p53 and the TGF-beta superfamily and implicate PTGF-beta as an important intercellular mediator of p53 function and the cytostatic effects of radiation and chemotherapeutic cancer agents.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1074/jbc.m909580199

Cites

88 of 88 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

WAF1, a potential mediator of p53 tumor suppression
El-Deiry, W. S., Tokino, T., Velculescu, V. E., Levy, D. B., Parsons, R., Trent, J. M., Lin, D., Mercer, W. E., Kinzler, K. W., & Vogelstein, B. (1993) · Cell · doi:10.1016/0092-8674(93)90500-p · Cited by 8,321
p53, the cellular gatekeeper for growth and division
Levine, A. J. (1997) · Cell · doi:10.1016/s0092-8674(00)81871-1 · Cited by 7,693
The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases.
Wade Harper, J. (1993) · Cell · doi:10.1016/0092-8674(93)90499-g · Cited by 5,651
p53, guardian of the genome
Lane, D. P. (1992) · Nature · doi:10.1038/358015a0 · Cited by 5,138
Prevention of Apoptosis by Bcl-2: Release of Cytochrome c from Mitochondria Blocked
Yang, J., Liu, X., Bhalla, K. N., Kim, C. N., Ibrado, A. M., Cai, J., Peng, T.-I., Jones, D. P., & Wang, X. (1997) · Science · doi:10.1126/science.275.5303.1129 · Cited by 4,913
Tumor suppressor p53 is a direct transcriptional activator of the human bax gene
Toshiyuki, M., & Reed, J. C. (1995) · Cell · doi:10.1016/0092-8674(95)90412-3 · Cited by 4,063
TGF-β signalling from cell membrane to nucleus through SMAD proteins
Heldin, C., Miyazono, K., & ten Dijke, P. (1997) · Nature · doi:10.1038/37284 · Cited by 3,697
The Transforming Growth Factor-Beta Family
Massagué, J. (1990) · Annual Review of Cell Biology · doi:10.1146/annurev.cb.06.110190.003121 · Cited by 3,041
p53-dependent apoptosis modulates the cytotoxicity of anticancer agents
Lowe, S. W., Ruley, H. E., Jacks, T., & Housman, D. E. (1993) · Cell · doi:10.1016/0092-8674(93)90719-7 · Cited by 2,911
Mutations in the p53 gene occur in diverse human tumour types
Nigro, J. M., Baker, S. J., Preisinger, A. C., Jessup, J. M., Hosteller, R., Cleary, K. R., Signer, S. H., Davidson, N. E., Baylin, S., Devilee, P., et al. (1989) · Nature · doi:10.1038/342705a0 · Cited by 2,730
Cell Cycle Control and Cancer
Hartwell, L. H., & Kastan, M. B. (1994) · Science · doi:10.1126/science.7997877 · Cited by 2,539
A model for p53-induced apoptosis
Polyak, K., Xia, Y., Zweier, J. L., Kinzler, K. W., & Vogelstein, B. (1997) · Nature · doi:10.1038/38525 · Cited by 2,500
Tumor suppressor p53 is a regulator of bcl-2 and bax gene expression in vitro and in vivo.
Miyashita, T., Krajewski, S., Krajewska, M., Wang, H., Lin, H., Liebermann, D. A., Hoffman‐Liebermann, B., & Reed, J. C. (1994) · PubMed · Cited by 2,143
Wild-type p53 induces apoptosis of myeloid leukaemic cells that is inhibited by interleukin-6
Yonish-Rouach, E., Resnftzky, D., Lotem, J., Sachs, L., Kimchi, A., & Oren, M. (1991) · Nature · doi:10.1038/352345a0 · Cited by 2,079
Definition of a consensus binding site for p53
El-Deiry, W. S., Kern, S. E., Pietenpol, J. A., Kinzler, K. W., & Vogelstein, B. (1992) · Nature Genetics · doi:10.1038/ng0492-45 · Cited by 1,985
p53 function and dysfunction
Vogelstein, B. (1992) · Cell · doi:10.1016/0092-8674(92)90421-8 · Cited by 1,849
A novel form of Epstein-Barr virus latency in normal B cells in vivo
Miyashita, E. M., Yang, B., Lam, K. M. C., Crawford, D., & Thorley‐Lawson, D. A. (1995) · Cell · doi:10.1016/0092-8674(95)90513-8 · Cited by 1,591
TGFβ signals through a heteromeric protein kinase receptor complex
Wrana, J. L., Attisano, L., Cárcamo, J. M., Zentella‐Dehesa, A., Doody, J. F., Laiho, M., Wang, X.-F., & Massagué, J. (1992) · Cell · doi:10.1016/0092-8674(92)90395-s · Cited by 1,528
Bax-Deficient Mice with Lymphoid Hyperplasia and Male Germ Cell Death
Knudson, C. M., Tung, K. S. K., Tourtellotte, W. G., Brown, G. A. J., & Korsmeyer, S. J. (1995) · Science · doi:10.1126/science.270.5233.96 · Cited by 1,492
p53 Status and the Efficacy of Cancer Therapy in Vivo
Lowe, S. W., Bodis, S. B., McClatchey, A. I., Remington, L., Ruley, H. E., Fisher, D. E., Housman, D. E., & Jacks, T. (1994) · Science · doi:10.1126/science.7973635 · Cited by 1,468
Life, death, and the pursuit of apoptosis.Preprint
White, E. (1996) · Genes & Development · doi:10.1101/gad.10.1.1 · Cited by 1,306
Is a p53-Regulated Inhibitor of G2/M Progression
Hermeking, H., Lengauer, C., Polyak, K., He, T.-C., Zhang, L., Thiagalingam, S., Kinzler, K. W., & Vogelstein, B. (1997) · Molecular Cell · doi:10.1016/s1097-2765(00)80002-7 · Cited by 1,251
MIC-1, a novel macrophage inhibitory cytokine, is a divergent member of the TGF-β superfamily
Bootcov, M. R., Bauskin, A. R., Valenzuela, S. M., Moore, A. G., Bansal, M., He, X. Y., Zhang, H. P., Donnellan, M., Mahler, S. M., Pryor, K., et al. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.21.11514 · Cited by 1,180
KILLER/DR5 is a DNA damage–inducible p53–regulated death receptor gene
Wu, G. S., Burns, T. F., McDonald, E. R., Jiang, W., Meng, R., Krantz, I. D., Kao, G., Gan, D.-D., Zhou, J.-Y., Muschel, R. J., et al. (1997) · Nature Genetics · doi:10.1038/ng1097-141 · Cited by 1,081
Transcriptional Activators of TGF-β Responses: Smads
Derynck, R., Zhang, Y. E., & Feng, X. (1998) · Cell · doi:10.1016/s0092-8674(00)81696-7 · Cited by 1,030
Transforming growth factor beta induces the cyclin-dependent kinase inhibitor p21 through a p53-independent mechanism.
Datto, M., Li, Y., Panus, J. F., Howe, D. J., Xiong, Y., & Wang, X. F. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.12.5545 · Cited by 945
Molecular regulation of apoptosis: Genetic controls on cell death
Williams, G. T., & Smith, C. A. (1993) · Cell · doi:10.1016/0092-8674(93)90457-2 · Cited by 914
Partnership between DPC4 and SMAD proteins in TGF-β signalling pathways
Lagna, G., Hata, A., Hemmati‐Brivanlou, A., & Massagué, J. (1996) · Nature · doi:10.1038/383832a0 · Cited by 905
Calcium phosphate-mediated gene transfer: a highly efficient transfection system for stably transforming cells with plasmid DNA.
Chen, C. A., & Okayama, H. (1990) · PubMed · Cited by 898
FADD: Essential for Embryo Development and Signaling from Some, But Not All, Inducers of Apoptosis
Yeh, W., de la Pompa, J. L., McCurrach, M. E., Shu, H., Elia, A., Shahinian, A., Ng, M. S. W., Wakeham, A. C., Khoo, W., Mitchell, K., et al. (1998) · Science · doi:10.1126/science.279.5358.1954 · Cited by 890
Bcl-2 prolongs cell survival after Bax-induced release of cytochrome c
Rossé, T., Olivier, R., Monney, L., Rager, M., Conus, S., Fellay, I., Jansen, B., & Borner, C. (1998) · Nature · doi:10.1038/35160 · Cited by 870
Induction of the growth inhibitor IGF-binding protein 3 by p53
Buckbinder, L., Talbott, R. L., Velasco-Miguel, S., Takenaka, I. M., Faha, B., Seizinger, B. R., & Kley, N. (1995) · Nature · doi:10.1038/377646a0 · Cited by 869
TGFβ Signaling: Receptors, Transducers, and Mad Proteins
Massagué, J. (1996) · Cell · doi:10.1016/s0092-8674(00)81296-9 · Cited by 836
Growth inhibition by TGF-β linked to suppression of retinoblastoma protein phosphorylation.
Laiho, M., DeCaprio, J. A., Ludlow, J. W., Livingston, D. M., & Massague, J. (1990) · Cell · doi:10.1016/0092-8674(90)90251-9 · Cited by 797
The winged-helix transcription factor HNF-3β is required for notochord development in the mouse embryo
Weinstein, D. C., Altaba, A. R. I., Chen, W. S., Hoodless, P. A., Prezioso, V. R., Jessell, T. M., & Darnell, J. E., Jr. (1994) · Cell · doi:10.1016/0092-8674(94)90523-1 · Cited by 783
An efficient and flexible system for construction of adenovirus vectors with insertions or deletions in early regions 1 and 3.
Bett, A. J., Haddara, W. M. R., PREVEC, L., & Graham, F. L. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.19.8802 · Cited by 742
Wild-Type Human p53 and a Temperature-Sensitive Mutant Induce Fas/APO-1 Expression
Owen‐Schaub, L. B., Zhang, W. K., Cusack, J. C., Angelo, L. S., Santee, S. M., Fujiwara, T., Roth, J. A., Deisseroth, A., Zhang, W., Kruzel, E., et al. (1995) · Molecular and Cellular Biology · doi:10.1128/mcb.15.6.3032 · Cited by 740
Apoptosis, p53, and tumor cell sensitivity to anticancer agents.
Brown, J. M., & Wouters, B. G. (1999) · PubMed · Cited by 696
TGF‐β induces fibronectin synthesis through a c‐Jun N‐terminal kinase‐dependent, Smad4‐independent pathway
Hocevar, B. A., Brown, T. L., & Howe, P. H. (1999) · The EMBO Journal · doi:10.1093/emboj/18.5.1345 · Cited by 681
DPC4 gene in various tumor types.
Schutte, M. E. M., Hruban, R. H., Hedrick, L., Cho, K. R., Nadasdy, G. M., Weinstein, C. L., Bova, G. S., Isaacs, W. B., Cairns, P., Nawroz, H., et al. (1996) · PubMed · Cited by 672
SMADs: mediators and regulators of TGF-β signaling
Kretzschmar, M., & Massagué, J. (1998) · Current Opinion in Genetics & Development · doi:10.1016/s0959-437x(98)80069-5 · Cited by 467
Identification of AML-1 and the (8;21) Translocation Protein (AML-1/ETO) as Sequence-Specific DNA-Binding Proteins: theruntHomology Domain is Required for DNA Binding and Protein-Protein Interactions
Meyers, S., Downing, J. R., & Hiebert, S. W. (1993) · Molecular and Cellular Biology · doi:10.1128/mcb.13.10.6336 · Cited by 462
Dual role of the Smad4/DPC4 tumor suppressor in TGFβ-inducible transcriptional complexesPreprint
Liu, F., Pouponnot, C., & Massagué, J. (1997) · Genes & Development · doi:10.1101/gad.11.23.3157 · Cited by 445
Functional Analysis of the Transforming Growth Factor βResponsive Elements in the WAF1/Cip1/p21 Promoter
Datto, M., Yu, Y., & Wang, X. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.48.28623 · Cited by 429
Translocation of SAPK/JNK to Mitochondria and Interaction with Bcl-xL in Response to DNA Damage
Kharbanda, S., Saxena, S., Yoshida, K., Pandey, P., Kaneki, M., Wang, Q., Cheng, K., Chen, Y.-N., Campbell, A., Sudha, T., et al. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.1.322 · Cited by 429
Regulation of the Apolipoprotein AI Gene by ARP-1, a Novel Member of the Steroid Receptor Superfamily
Ladias, J. A. A., & Karathanasis, S. K. (1991) · Science · doi:10.1126/science.1899293 · Cited by 371
The tumor suppressor Smad4/DPC 4 as a central mediator of Smad function
Zhang, Y. E., Musci, T. J., & Derynck, R. (1997) · Current Biology · doi:10.1016/s0960-9822(06)00123-0 · Cited by 310
Cloning and Characterization of a Novel Member of the Transforming Growth Factor-β/Bone Morphogenetic Protein Family
Paralkar, V. M., Vail, A. L., GRASSER, W. A., Brown, T. A., Xu, H., Vukičević, S., Ke, H. Z., Qi, H., Owen, T. A., & Thompson, D. D. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.22.13760 · Cited by 289
Molecular controls of growth arrest and apoptosis: p53-dependent and independent pathways.
Liebermann, D. A., Hoffman, B., & Steinman, R. A. (1995) · PubMed · Cited by 282
Solution structure of the tetrameric minimum transforming domain of p53
Lee, W., Harvey, T. S., Yin, Y., Yau, P., Litchfield, D. W., & Arrowsmith, C. H. (1994) · Nature Structural & Molecular Biology · doi:10.1038/nsb1294-877 · Cited by 268
Self-citation
Coupling gene expression to cAMP signalling: role of CREB and CREM
Sassone‐Corsi, P. (1998) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/s1357-2725(97)00093-9 · Cited by 244
Dismantling Cell–Cell Contacts during Apoptosis Is Coupled to a Caspase-dependent Proteolytic Cleavage of β-Catenin
Brancolini, C., Lazarević, D., Rodriguez, J., & Schneider, C. (1997) · The Journal of Cell Biology · doi:10.1083/jcb.139.3.759 · Cited by 236
PLAB, a novel placental bone morphogenetic protein
Hromas, R., Hufford, M. B., Sutton, J., Xu, D., Li, Y., & Lu, L. (1997) · Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression · doi:10.1016/s0167-4781(97)00122-x · Cited by 233
Characterization of the stress-inducing effects of homocysteine
Outinen, P. A., Sood, S. K., LIAW, P. C. Y., Sarge, K. D., Maeda, N., Hirsh, J., Ribau, J. C. O., Podor, T. J., Weitz, J. I., & Austin, R. C. (1998) · Biochemical Journal · doi:10.1042/bj3320213 · Cited by 232
Self-citation
The Lymphoid Transcription Factor LyF-1 Is Encoded by Specific, Alternatively Spliced mRNAs Derived from the Ikaros Gene
Hahm, K., Ernst, P., Lo, K., Kim, G. S., Turck, C. W., & Smale, S. T. (1994) · Molecular and Cellular Biology · doi:10.1128/mcb.14.11.7111 · Cited by 224
Identification of a novel member of the TGF-beta superfamily highly expressed in human placenta
Lawton, L. N., Bonaldo, M. F., Jelenc, P. C., Qiu, L., Baumes, S. A., Marcelino, R. A., de Jesus, G. M., Wellington, S., Knowles, J. A., Warburton, D., et al. (1997) · Gene · doi:10.1016/s0378-1119(97)00485-x · Cited by 209
The state of the STATs: recent developments in the study of signal transduction to the nucleus
Horvath, C. M., & Darnell, J. E., Jr. (1997) · Current Opinion in Cell Biology · doi:10.1016/s0955-0674(97)80067-1 · Cited by 208
Serine/threonine kinase receptors: mediators of transforming growth factor beta family signals.
Massagué, J., & Weis‐Garcia, F. (1996) · PubMed · Cited by 196
Cancer therapy and p53
Lowe, S. W. (1995) · Current Opinion in Oncology · doi:10.1097/00001622-199511000-00013 · Cited by 193
Connective Tissue Growth Factor Induces Apoptosis in Human Breast Cancer Cell Line MCF-7
Hishikawa, K., Oemar, B. S., Tanner, F. C., Nakaki, T., Lüscher, T. F., & Fujii, T. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.52.37461 · Cited by 178
A novel p53‐inducible gene, PAG608, encodes a nuclear zinc finger protein whose overexpression promotes apoptosis
Israeli, D., Tessler, E., Haupt, Y., Elkeles, A., Wilder, S., Amson, R. B., Telerman, A., & Oren, M. (1997) · The EMBO Journal · doi:10.1093/emboj/16.14.4384 · Cited by 172
Overlapping roles and asymmetrical cross-regulation of the USF proteins in mice
Sirito, M., Lin, Q., Deng, J. M., Behringer, R. R., & Sawadogo, M. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.7.3758 · Cited by 163
The MEK Pathway Is Required for Stimulation of p21WAF1/CIP1 by Transforming Growth Factor-β
Hu, P. P.-C., Shen, X., Huang, D., Liu, Y. I., Counter, C. M., & Wang, X.-F. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.50.35381 · Cited by 157
Tumor Suppressor p53 Can Participate in Transcriptional Induction of the GADD45 Promoter in the Absence of Direct DNA Binding
Zhan, Q., Chen, I. T., Antinore, M. J., & Fornace, A. J. (1998) · Molecular and Cellular Biology · doi:10.1128/mcb.18.5.2768 · Cited by 154
DPC4 (SMAD4) mediates transforming growth factor-β1 (TGF-β1) induced growth inhibition and transcriptional response in breast tumour cells
de Winter, J. P., Roelen, B. A. J., ten Dijke, P., van der Burg, B., & Raaij, A. J. M. V. D. E.-V. (1997) · Oncogene · doi:10.1038/sj.onc.1201017 · Cited by 133
p53-dependent DNA damage-induced apoptosis requires Fas/APO-1-independent activation of CPP32beta.
Fuchs, E. J., Mckenna, K. A., & Bedi, A. (1997) · PubMed · Cited by 132
[20] Analysis of altered gene expression by differential display
Liang, P., Bauer, D., Averboukh, L., Warthoe, P., Rohrwild, M., Müller, H., Strauss, M., & Pardee, A. B. (1995) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/0076-6879(95)54022-9 · Cited by 129
Recombinant adenovirus expressing wild-type p53 is antiangiogenic: a proposed mechanism for bystander effect.
Nishizaki, M., Fujiwara, T., Tanida, T., HIZUTA, A., Nishimori, H., Tokino, T., Nakamura, Y., Bouvet, M., Roth, J., & Tanaka, N. (1999) · PubMed · Cited by 118
Human cDNA Encoding a Novel TGF- Superfamily Protein Highly Expressed in Placenta
Yokoyama-Kobayashi, M., Saeki, M., Sekine, S., & Kato, S. (1997) · The Journal of Biochemistry · doi:10.1093/oxfordjournals.jbchem.a021798 · Cited by 116
Tamoxifen induces TGF-beta 1 activity and apoptosis of human MCF-7 breast cancer cells in vitro.
Chen, H., Tritton, T. R., Kenny, N., Absher, M. P., & Chiu, J. (1996) · PubMed · doi:10.1002/(sici)1097-4644(19960401)61:1%3c9::aid-jcb2%3e3.0.co;2-z · Cited by 107
Cytotoxic effects of adenovirus-mediated wild-type p53 protein expression in normal and tumor mammary epithelial cells.
Katayose, D., Gudas, J. M., Nguyen, H., Srivastava, S., Cowan, K. H., & Seth, P. K. (1995) · PubMed · Cited by 106
Regulation of GATA-2 Phosphorylation by Mitogen-activated Protein Kinase and Interleukin-3
Towatari, M., May, G. E., Marais, R., Perkins, G. R., Marshall, C. J., Cowley, S. A., & Enver, T. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.8.4101 · Cited by 101
A novel p53‐inducible gene coding for a microtubule‐localized protein with G2‐phase‐specific expression
Utrera, R., Collavin, L., Lazarević, D., Delia, D., & Schneider, C. (1998) · The EMBO Journal · doi:10.1093/emboj/17.17.5015 · Cited by 98
Mechanism and Function of Signaling by the TGFβ Superfamily
Hoodless, P. A., & Wrana, J. L. (1998) · Current topics in microbiology and immunology · doi:10.1007/978-3-642-80481-6_10 · Cited by 82
DNA damage, p53 and anticancer therapies
Milner, J. (1995) · Nature Medicine · doi:10.1038/nm0995-879 · Cited by 68
Bystander effect in the adenovirus-mediated wild-type p53 gene therapy model of human squamous cell carcinoma of the head and neck.
Frank, D. K., Frederick, M. J., Liu, T. J., & Clayman, G. L. (1998) · PubMed · Cited by 50
Cooperation between p53-dependent and p53-independent apoptotic pathways in myeloid cells.
Peled, A., Zipori, D., & Rotter, V. (1996) · PubMed · Cited by 48
ICE-like protease (caspase) is involved in transforming growth factor β1-mediated apoptosis in FaO rat hepatoma cell line
Choi, K. S., Lim, I. K., Brady, J. N., & Kim, S. (1998) · Hepatology · doi:10.1002/hep.510270215 · Cited by 46
A role for CdxA in gut closure and intestinal epithelia differentiation
Frumkin, A., Pillemer, G., Haffner, R., Tarcic, N., Gruenbaum, Y., & Fainsod, A. (1994) · Development · doi:10.1242/dev.120.2.253 · Cited by 43
Accentuated apoptosis in normally developing p53 knockout mouse embryos following genotoxic stress
Frenkel, J., Sherman, D., Fein, A., Schwartz, D., Almog, N., Kapon, A., Goldfinger, N., & Rotter, V. (1999) · Oncogene · doi:10.1038/sj.onc.1202518 · Cited by 39
Fas (APO-1/CD95) signaling pathway is intact in radioresistant human glioma cells.
Yount, G. L., Levine, K. S., Kuriyama, H., Haas-Kogan, D. A., & Israel, M. A. (1999) · PubMed · Cited by 35
Tumor Suppressor Gene Smad4/DPC4, Its Downstream Target Genes, and Regulation of Cell Cyclea
Chiao, P. J., Hunt, K. K., Grau, A. M., Abramian, A., Fleming, J. B., ZHANG, W., Breslin, T. M., Abbruzzese, J. L., & Evans, D. B. (1999) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1999.tb09507.x · Cited by 33
The evaluation of adenoviral p53-mediated bystander effect in gene therapy of cancer
Rizk, N. P., Chang, M. Y., Kouri, C. E., Seth, P. K., Kaiser, L. R., Albelda, S. Μ., & Amin, K. M. (1999) · Cancer Gene Therapy · doi:10.1038/sj.cgt.7700059 · Cited by 31
Differential chemosensitivity of breast cancer cells to ganciclovir treatment following adenovirus-mediated herpes simplex virus thymidine kinase gene transfer
Li, P.-X., Ngo, D., Brade, A. M., & Klamut, H. J. (1999) · Cancer Gene Therapy · doi:10.1038/sj.cgt.7700005 · Cited by 19
Self-citation
Therapeutic potential of recombinant p53 overexpression in breast cancer cells expressing endogenous wild-type p53
Pei-xiang, L., Bui, T., Gray, D. M., & Klamut, H. J. (1998) · Breast Cancer Research and Treatment · doi:10.1023/a:1005961705860 · Cited by 13
Self-citation
DNA-Binding Activity of Wild-Type p53 Protein is Mediated by the Central Part of the Molecule and Controlled by Its C Terminus
Wolkowicz, R., Peled, A., Elkind, B., & Rotter, V. (1998) · Cancer Detection and Prevention · doi:10.1046/j.1525-1500.1998.00003.x · Cited by 13
Molecular targets to overcome radioresistance.
Weichselbaum, R. R., Beckett, M. A., Hallahan, D. E., Kufe, D. W., & Vokes, E. E. (1992) · PubMed · Cited by 12
Influence of subunit transcript and protein levels on formation of a mitochondrial multienzyme complex
McConnell, B. B., McKean, M. C., & Danner, D. J. (1996) · Journal of Cellular Biochemistry · doi:10.1002/(sici)1097-4644(19960401)61:1 · Cited by 12

Research works printed but not linked: 16

Weichselbaum, 1992, Semin. Oncol., 19, 14
Miyashita, 1994, Oncogene, 9, 1799
Fuchs, 1997, Cancer Res., 57, 2550
Yount, 1999, Cancer Res., 59, 1362
Brown, 1999, Cancer Res., 59, 1391
Peled, 1996, Cancer Res., 56, 2148
Hoodless, 1998, Curr. Topics Microbiol. Immunol., 228, 235
Chen, 1988, BioTechniques, 6, 632
Liebermann, 1995, Oncogene, 11, 199
Nishizaki, 1999, Clin. Cancer Res., 5, 1015
Meyers, 1993, Mol. Cell. Biol., 13, 6336
Hahm, 1994, Mol. Cell. Biol., 14, 7111
Katayose, 1995, Clin. Cancer Res., 1, 889
Massague, 1996, Cancer Surv., 27, 41
Schutte, 1996, Cancer Res., 56, 2527
Frank, 1998, Clin. Cancer Res., 4, 2521

Sorted by citations

Cyclooxygenase‐independent actions of cyclooxygenase inhibitors
Tegeder, I., Pfeilschifter, J. M., & Geißlinger, G. (2001) · The FASEB Journal · doi:10.1096/fj.01-0390rev · Cited by 755
Activation of p53 by MEG3 Non-coding RNA
Zhou, Y., Zhong, Y., Wang, Y., Zhang, X., Batista, D. L., Gejman, R., Ansell, P. J., Zhao, J. C., Weng, C., & Klibanski, A. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m702029200 · Cited by 665
Members of the heat-shock protein 70 family promote cancer cell growth by distinct mechanismsPreprint
Rohde, M., Daugaard, M., Jensen, M. H., Helin, K., Nylandsted, J., & Jäättelä, M. (2005) · Genes & Development · doi:10.1101/gad.305405 · Cited by 417
The MIC-1/GDF15-GFRAL Pathway in Energy Homeostasis: Implications for Obesity, Cachexia, and Other Associated Diseases
Tsai, V. W.-W., Husaini, Y., Sainsbury, A., Brown, D. A., & Breit, S. N. (2018) · Cell Metabolism · doi:10.1016/j.cmet.2018.07.018 · Cited by 424
Cyclooxygenase Inhibitors Regulate the Expression of a TGF-β Superfamily Member That Has Proapoptotic and Antitumorigenic Activities
Baek, S. J., Kim, K. S., Nixon, J. B., Wilson, L. C., & Eling, T. E. (2001) · Molecular Pharmacology · doi:10.1124/mol.59.4.901 · Cited by 402

See all 254

Authors: Li, P.-X., Wong, J., Ayed, A., Ngo, D., Brade, A. M., Arrowsmith, C., Austin, R. C., & Klamut, H. J.
Affiliations: University Health Network (CA)
McMaster University (CA)
Corresponding author: Klamut, Henry J.
ORCID: Arrowsmith, Cheryl
Austin, Richard C.
Venue: Journal of Biological Chemistry
Publisher: Elsevier BV
Published: 2000-06
Volume: 275
Issue: 26
Pages: 20127-20135
ISSN: 0021-9258 (ISSN-L)
DOI: 10.1074/jbc.m909580199
OpenAlex: W2126527070
Cited by: 254
References: 88
Citations by year: 2026: 2 · 2025: 3 · 2024: 5 · 2022: 3 · 2021: 8 · 2020: 13 · 2019: 10 · 2018: 10 · 2017: 9 · 2016: 6 · 2015: 11 · 2014: 9 · 2013: 10 · 2012: 12
FWCI: 3.50
Type: journal article
Language: en
Open access: hybrid
doi.org
Licence: cc-by
www.elsevier.com/tdm/userlicense/1.0/ (tdm)
creativecommons.org/licenses/by/4.0/ (vor, 7431 d)
Locations: Journal of Biological Chemistry (publishedVersion, cc-by)
PubMed (publishedVersion)
Funders: Medical Research Council Canada
Medical Research Council
Topics: Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › TGF-β signaling in diseases
Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Cell death mechanisms and regulation
Keywords: TGF-beta superfamily, p53, DNA damage, apoptosis, G1 cell cycle arrest, breast cancer, p53 binding sites, promoter induction, adenoviral overexpression, radiation-induced cell death, chemotherapeutic drug resistance
MeSH terms: Adenoviridae, Breast Neoplasms, Cell Cycle, Cell Division, Cell Survival, DNA Damage, Genetic Vectors, Growth Substances, Humans, Pregnancy Proteins, RNA, Messenger, Time Factors, Tissue Distribution, Tumor Cells, Cultured, Blotting, Northern, Transcriptional Activation, Up-Regulation, Genes, p53, Tumor Suppressor Protein p53, Apoptosis, Sequence Analysis, DNA, DNA, Complementary

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Placental Transforming Growth Factor-β Is a Downstream Mediator of the Growth Arrest and Apoptotic Response of Tumor Cells to DNA Damage and p53 Overexpression

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks